He F, Wu C, Tu Q, Xing G
Department of Experimental Hematology, Beijing Institute of Radiation Medicine, China.
Hepatology. 1993 Feb;17(2):225-9.
Cloning of human hepatic stimulator substance requires clarification of whether the substance is the product of gene expression of liver cells. In this article the translation experiment in Xenopus laevis oocytes indicates that poly (A)+ messenger RNA of human fetal liver cells could conduct the biosynthesis of human hepatic stimulator substance. The translated human hepatic stimulator substance is a heat-, acid- and alkaline-resistant, but specific hepatic-stimulating, protein with a molecular weight in the range of 10 to 30 kD and with secreting ability. The characteristics of the translated human hepatic stimulator substance are consistent with those of biochemically purified human hepatic stimulator substance from human fetal liver cells. These results demonstrate that human hepatic stimulator substance is a product of gene expression of human fetal liver cells and that the complementary DNA of human hepatic stimulator substance could be screened from the complementary DNA library of human fetal liver tissue.
人肝刺激物质的克隆需要明确该物质是否为肝细胞基因表达的产物。本文在非洲爪蟾卵母细胞中的翻译实验表明,人胎肝细胞的聚腺苷酸(poly(A)+)信使核糖核酸(mRNA)能够指导人肝刺激物质的生物合成。翻译得到的人肝刺激物质是一种耐热、耐酸和耐碱,但具有特异性肝刺激作用的蛋白质,分子量在10至30千道尔顿之间,且具有分泌能力。翻译得到的人肝刺激物质的特性与从人胎肝细胞中经生化纯化得到的人肝刺激物质的特性一致。这些结果表明,人肝刺激物质是人胎肝细胞基因表达的产物,并且可以从人胎肝组织的互补DNA文库中筛选出人肝刺激物质的互补DNA。